USANA Health Sciences has announced a significant acquisition, securing a 78.8% controlling stake in Hiya Health Products for $205 million in cash. The deal, finalized on December 23, 2024, is projected to positively impact USANA’s adjusted EBITDA for 2025.
Hiya Health, recognized for providing high-quality health and wellness products aimed at children, reported net sales of $103 million and net income of $19 million for the year ending September 30, 2024. To date, it has attracted over 200,000 customers.
The acquisition aligns with USANA’s strategy to expand its reach within the children’s health market. Hiya’s impressive growth trajectory, showcasing a 50% increase in net sales year-over-year, is anticipated to continue with an estimated growth of 30% in fiscal year 2025.
USANA’s President and CEO, Jim Brown, remarked, ‘The Hiya brand is a natural fit for USANA and this acquisition represents a key strategic milestone for our business.’ He emphasized the alignment between Hiya’s mission and USANA’s commitment to health and wellness.
Additionally, the integration of Hiya is expected to provide USANA with enhanced distribution channels and greater market access through Hiya’s subscription model. This acquisition also allows USANA to capitalize on synergies between both companies’ strengths, particularly in manufacturing and marketing.
Darren Litt, co-founder and CEO of Hiya, stated, ‘We are thrilled to join the USANA family. With USANA’s support, we can extend our commitment to creating healthy products for families across more countries.’
The transaction was financed through a combination of cash and USANA’s existing credit facilities. Financial advice during this transaction was led by BofA Securities for USANA, while William Hood & Company represented Hiya.
Comments are closed